CompletedPhase 2

Radiotherapy of Head and Neck Cancer Using an Intraoral Stent

Norway220 participantsStarted 2020-01-01

Plain-language summary

Radiotherapy of oral cavity cancer and sinonasal cancer is associated with acute and late morbidity. Use of an intraoral stent will provide a larger distance between the tongue and palate and can reduce side-effects. The aim of the present study is to confirm that an intraoral stent is not a significant bother to the patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Radiation dose 30 Gy or higher * Cancer in the inferior part of the oral cavity (e.g. tongue or floor of mouth cancer) or superior part of the oral cavity (e.g. hard palate) or sinonasal cancer * Eastern Cooperative Oncology Group (ECOG) performance status 0-3 * Ability to understand and answer questionnaire Exclusion Criteria: None

What they're measuring

Patient-reported outcome

Timeframe: At the end of radiotherapy (5-6 weeks)

Trial details

NCT IDNCT04330781

SponsorOslo University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-03

View on ClinicalTrials.gov More Oral Cavity Cancer trials